Strontium ranelate: The first dual acting treatment for postmenopausal osteoporosis

Clinical Orthopaedics and Related Research

Volumn 443, Issue , 2006, Pages 55-60

  Burlet, Nansa ^a   Reginster, Jean Yves ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Policliniques L BRULL Quai Godefroid Kurth   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; STRONTIUM RANELATE; ORGANOMETALLIC COMPOUND; THIOPHENE DERIVATIVE;

CLINICAL TRIAL; CONFERENCE PAPER; DERMATITIS; DIARRHEA; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ECZEMA; FRAGILITY FRACTURE; GASTROINTESTINAL SYMPTOM; HIGH RISK PATIENT; HIP FRACTURE; HUMAN; IN VIVO STUDY; LIVER TOXICITY; NAUSEA; NEPHROTOXICITY; NONHUMAN; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SKELETON; VERTEBRA DISLOCATION; ANIMAL; BONE DENSITY; DRUG EFFECT; FEMALE; FRACTURE; REVIEW; TREATMENT OUTCOME;

ANIMALS; BONE DENSITY; FEMALE; FRACTURES, BONE; HUMANS; ORGANOMETALLIC COMPOUNDS; OSTEOPOROSIS, POSTMENOPAUSAL; THIOPHENES; TREATMENT OUTCOME;

EID: 33645298532     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000200247.27253.e9     Document Type: Conference Paper

References (21)

1. Ammann P, Shen V, Robin B, et al. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats. J Bone Miner Res. for evaluating their respective anti-fracture efficacy 2004;19:2012-2020.
2. Baron R, Tsouderos Y. In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol. 2002;450:11-17.
3. Bengner U, Johnell O, Redlund-Johnell I. Changes in incidence and prevalence of vertebral fractures during 30 years. Calcif Tissue Int. 1988;42:293-296.
4. Boivin G, Deloffre P, Perrat B, et al. Strontium distribution and interactions with bone mineral density in monkey iliac bone after strontium salt (S12911) administration. J Bone Miner Res. 1996;11:1302-1311.
5. Buehler J, Chappuis P, Saffar JL, Tsouderos Y, Vignery A. Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis). Bone. 2001;29:176-179.
6. Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone. 1996;18:517-523.
7. Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med. 1998;338:736-746.
8. Genant HK, Wu CY, Van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semi-quantitative technique. J Bone Miner Res. 1993;8:1137-1148.
9. Hott M, Deloffre P, Tsouderos Y, Maire PJ. S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone. 2003;33:115-123.
10. Incidence of vertebral fracture in Europe: Results from the European Prospective Osteoporosis Study. J Bone Miner Res. 2002;17:716-724.
11. Marcus R, Wong M, Heath H III, Stock JL. Antiresorptive treatment of postmenopausal osteoporosis: Comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. Endocr Rev. 2002;23:16-37.
12. Marie PJ, Ammann P, Boivin G, Rey C. Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int. 2001;69:121-129.
13. Marie PJ, Hott M, Modrowski D, et al. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res. 1993;8:607-615.
14. Meunier PJ, Roux C, Seeman E, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with post menopausal osteoporosis. N Engl J Med. 2004;350:459-468.
15. Meunier PJ, Slosman D, Delmas P, et al. Strontium ranelate: Dose-dependent effects in established postmenopausal vertebral osteoporosis. A 2-year randomized placebo controlled trial. J Clin Endocrinol Metab. 2002;87:2060-2066.
16. Morohashi T, Sano T, Harai K, Yamada S. Effects of strontium on calcium metabolism in rats. II: Strontium prevents the increased rate of bone turnover in ovariectomized rats. Jpn J Pharmacol. 1995;68:153-159.
17. Quarles LD. Cation sensing receptors in bone: A novel paradigm for regulating bone remodeling? J Bone Miner Res. 1997;12:1971-1974.
18. Reginster JY, Seeman E, De Vernejoul MC, et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab. 2005;90:2816-2822.
19. Seeman E. Pathogenesis of bone fragility in women and men. Lancet. 2002;359:1841-1850.
20. Takahashi N, Sasaki T, Tsouderos Y, Suda T. S12911-2 inhibits osteoclastic bone resorption in vitro. J Bone Miner Res. 2003;18:1082-1087.
21. van Schoor NM, Smit JH, Twisk JW, Bouter LM, Lips P. Prevention of hip fractures by external hip protectors: A randomized controlled trial. JAMA. 2003;289:1957-1962.